| [1] |
National Cancer Institute. SEER Cancer Statistics Factsheets: Thyroid Cancer[EB/OL]. [2019-04-21]. http://seer.cancer.gov/statfacts/html/thyro.html. |
| [2] |
Chen WQ, Zheng RS, Baade PD, et al.
Cancer statistics in China, 2015[J]. CA Cancer J ClinCA Cancer J Clin, 2016, 66(2): 115-132.
doi: 10.3322/caac.21338 |
| [3] |
Kasinski AL, Slack FJ.
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy[J]. Nat Rev CancerNat Rev Cancer, 2011, 11(12): 849-864.
doi: 10.1038/nrc3166 |
| [4] |
Shen CT, Qiu ZL, Song HJ, et al.
miRNA-106a directly targeting RARB associates with the expression of Na+/I- symporter in thyroid cancer by regulating MAPK signaling pathway[J]. J Exp Clin Cancer ResJ Exp Clin Cancer Res, 2016, 35(1): 101-.
doi: 10.1186/s13046-016-0377-0 |
| [5] |
Vriens MR, Weng J, Suh I, et al.
MicroRNA Expression Profiling Is a Potential Diagnostic Tool for Thyroid Cancer[J]. CancerCancer, 2012, 118(13): 3426-3432.
doi: 10.1002/cncr.26587 |
| [6] |
Riesco-Eizaguirre G, Wert-Lamas L, Perales-Patón J, et al.
The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells During Carcinogenesis[J]. Cancer ResCancer Res, 2015, 75(19): 4119-4130.
doi: 10.1158/0008-5472.CAN-14-3547 |
| [7] |
Lee J, Soh EY.
Differentiated Thyroid Carcinoma Presenting With Distant Metastasis at Initial Diagnosis: Clinical Outcomes and Prognostic Factors[J]. Ann SurgAnn Surg, 2010, 251(1): 114-119.
doi: 10.1097/SLA.0b013e3181b7faf6 |
| [8] |
Cho SW, Choi HS, Yeom GJ, et al.
Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and its Prognostic Factors[J]. ThyroidThyroid, 2014, 24(2): 277-286.
doi: 10.1089/thy.2012.0654 |
| [9] |
Schlumberger M, Brose M, Elisei R, et al.
Definition and management of radioactive iodine-refractory differentiated thyroid cancer[J]. Lancet Diabetes EndocrinolLancet Diabetes Endocrinol, 2014, 2(5): 356-358.
doi: 10.1016/S2213-8587(13)70215-8 |
| [10] |
Feng F, Wang H, Hou SS, et al.
Re-induction of cell differentiation and 131I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection[J]. Nucl Med BiolNucl Med Biol, 2012, 39(8): 1261-1265.
doi: 10.1016/j.nucmedbio.2012.07.004 |
| [11] |
He HL, Jazdzewski K, Li W, et al.
The role of microRNA genes in Papillary thyroid carcinoma[J]. Proc Natl Acad Sci U S AProc Natl Acad Sci U S A, 2005, 102(52): 19075-19080.
doi: 10.1073/pnas.0509603102 |
| [12] |
Chou CK, Chen RF, Chou FF, et al.
miR-146b is Highly Expressed in Adult Papillary Thyroid Carcinomas with High Risk Features Including Extrathyroidal Invasion and the BRAFV600E Mutation[J]. ThyroidThyroid, 2010, 20(5): 489-494.
doi: 10.1089/thy.2009.0027 |
| [13] |
Chou CK, Yang KD, Chou FF, et al.
Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma[J]. J Clin Endocrinol MetabJ Clin Endocrinol Metab, 2013, 98(2): E196-E205.
doi: 10.1210/jc.2012-2666 |
| [14] |
Bastos AU, Oler G, Nozima BHN, et al.
BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma[J]. Eur J EndocrinolEur J Endocrinol, 2015, 173(4): 525-540.
doi: 10.1530/EJE-15-0254 |
| [15] |
Lee JC, Zhao JT, Clifton-Bligh RJ, et al.
MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer[J]. CancerCancer, 2013, 119(24): 4358-4365.
doi: 10.1002/cncr.28254 |
| [16] |
Huang YR, Yu S, Cao ST, et al.
MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression[J]. ThyroidThyroid, 2018, 28(9): 1162-1173.
doi: 10.1089/thy.2017.0665 |
| [17] |
Galardi S, Mercatelli N, Farace MG, et al.
NF-κB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells[J]. Nucleic Acids ResNucleic Acids Res, 2011, 39(9): 3892-3902.
doi: 10.1093/nar/gkr006 |
| [18] |
Weber F, Teresi RE, Broelsch CE, et al.
A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma[J]. J Clin Endocrinol MetabJ Clin Endocrinol Metab, 2006, 91(9): 3584-3591.
doi: 10.1210/jc.2006-0693 |
| [19] |
Nikiforova MN, Tseng GC, Steward D, et al.
MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility[J]. J Clin Endocrinol MetabJ Clin Endocrinol Metab, 2008, 93(5): 1600-1608.
doi: 10.1210/jc.2007-2696 |
| [20] |
Chi JD, Zheng XQ, Gao M, et al.
Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors[J]. Oncol LettOncol Lett, 2017, 14(6): 7153-7160.
doi: 10.3892/ol.2017.7146 |
| [21] |
张建祥, 马艳梅, 张素琴, 等.
血浆微小RNA-21鉴别甲状腺滤泡癌与乳头状甲状腺癌[J]. 中华实验外科杂志中华实验外科杂志, 2018, 35(10): 1921-1923.
doi: 10.3760/cma.j.issn.1001-9030.2018.10.043 Zhang JX, Ma YM, Zhang SQ, et al. Identification of thyroid follicular carcinoma and papillary thyroid carcinoma by plasma microRNA-21[J]. Chin J Exp SurgChin J Exp Surg, 2018, 35(10): 1921-1923. doi: 10.3760/cma.j.issn.1001-9030.2018.10.043 |
| [22] |
Visone R, Pallante P, Vecchione A, et al.
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas[J]. OncogeneOncogene, 2007, 26(54): 7590-7595.
doi: 10.1038/sj.onc.1210564 |
| [23] |
Esposito F, Tornincasa M, Pallante P, et al.
Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2[J]. J Clin Endocrinol MetabJ Clin Endocrinol Metab, 2012, 97(5): E710-E718.
doi: 10.1210/jc.2011-3068 |
| [24] |
Braun J, Hoang-Vu C, Dralle H, et al.
Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas[J]. OncogeneOncogene, 2010, 29(29): 4237-4244.
doi: 10.1038/onc.2010.169 |
| [25] |
Fuziwara CS, Kimura ET.
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology[J]. Int J EndocrinolInt J Endocrinol, 2014, 2014: 743450-.
doi: 10.1155/2014/743450 |
| [26] |
Mian C, Pennelli G, Fassan M, et al.
MicroRNA Profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome[J]. ThyroidThyroid, 2012, 22(9): 890-896.
doi: 10.1089/thy.2012.0045 |
| [27] |
Abraham D, Jackson N, Gundara JS, et al.
MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets[J]. Clin Cancer ResClin Cancer Res, 2011, 17(14): 4772-4781.
doi: 10.1158/1078-0432.CCR-11-0242 |
| [28] |
Gundara JS, Zhao JT, Gill AJ, et al.
Nodal metastasis microRNA expression correlates with the primary tumour in MTC[J]. ANZ J SurgANZ J Surg, 2014, 84(4): 235-239.
doi: 10.1111/j.1445-2197.2012.06291.x |
| [29] |
Shi L, Zhao SM, Luo Y, et al.
MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses[J]. Pathol Res PractPathol Res Pract, 2017, 213(11): 1344-1354.
doi: 10.1016/j.prp.2017.09.024 |